Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs NRG Energy Inc (NRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs NRG Energy Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while NRG Energy Inc trades at $98.41 (market cap $21.20B). The key difference: NRG Energy Inc is far larger — about 2.4× Kymera Therapeutics Inc. Common Stock's market cap, and NRG Energy Inc pays a 1.88% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and NRG Energy Inc for 63 Days on average.
| KYMR | NRG | |
|---|---|---|
Market Cap | $8.88B | $21.20B |
Volume | 1,028,790 | 2,487,856 |
Sector | Health | Utilities |
52-Week High | $127.31 | $184.03 |
52-Week Low | $55.80 | $95.23 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $8.27B | $45.15B |
Dividend Yield | — | 1.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NRG Energy trades at $107.18, up 0.76% on the day, with a neutral technical signal and bearish moving averages. The company reported mixed Q2 2026 earnings, missing estimates but showing strong EBITDA growth of 34% year-over-year. Recent news highlights a major 1.2 GW Texas data center power project and potential acquisition interest in a West Virginia coal plant. Analyst consensus remains strongly bullish with a $202.90 price target, though recent quarters have seen earnings misses.
The outlook is supported by strategic growth initiatives and solid cash flow, but risks include rising debt levels and execution challenges. The stock offers potential upside from analyst targets, but investors face volatility from earnings inconsistency and high leverage. The current valuation appears reasonable with a P/E of 27.91 and P/S of 0.66, balancing growth prospects with financial risk.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →
